Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method
- 31 May 2007
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 58 (1) , 129-132
- https://doi.org/10.1016/j.diagmicrobio.2006.10.017
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Assessment of the Paradoxical Effect of Caspofungin in Therapy of CandidiasisAntimicrobial Agents and Chemotherapy, 2006
- Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. IsolatesAntimicrobial Agents and Chemotherapy, 2005
- Impact of real-time fungal susceptibility on clinical practicesCurrent Opinion in Infectious Diseases, 2004
- Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug ConcentrationsAntimicrobial Agents and Chemotherapy, 2004
- Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus SpeciesJournal of Clinical Microbiology, 2004
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- MicafunginDrugs, 2004
- Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensisJournal of Antimicrobial Chemotherapy, 2001
- Antifungal Susceptibility Testing: Practical Aspects and Current ChallengesClinical Microbiology Reviews, 2001
- Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agentsDiagnostic Microbiology and Infectious Disease, 1989